Michael Boxer - Concepedia

Author

Michael Boxer

Arizona Oncology ORCID

Also Known As

M Adam L Boxer, M Boxer, M. Boxer, Michael A Boxer, Michael A. Boxer, Michael Boxer

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Arizona Oncology Willamette Valley Cancer Institute and Research Center Cornell University Rigel (United States)University of California San Diego

About

Michael Boxer is an author at Arizona Oncology specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	908
2	Health Sciences	6	6	334
3	Public Health	2	2	244
4	Cell Biology	1	1	12
5	Clinical Nutrition	1	1	83

Michael Boxer

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
The risk of Parkinson's disease in type 1 Gaucher disease Gilberto Bultron, Katherine Kacena, Daniel S. Pearson, Journal of Inherited Metabolic Disease	2010	215
An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia Jeff P. Sharman, Michael Hawkins, Kathryn S. Kolibaba, Blood	2015	181
Thromboembolic Risk of Postsplenectomy Thrombocytosis Michael Boxer Archives of Surgery Retrospective StudyThrombosisThrombopoiesisVenous ThrombosisCardiovascular Disease	1978	165
The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients Tamar H. Taddei, Katherine Kacena, Mei Yang, American Journal of Hematology GeneticsGenetic EpidemiologyPathologySubstrate Reduction TherapyDisease Gene Identification	2009	155
The lupus anticoagulant Michael Boxer, Leonard Ellman, Angelina C. A. Carvalho Arthritis & Rheumatism ImmunologyPathologyLupus AnticoagulantThrombosisHematology	1976	143
Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program James B. Bussel, Donald M. Arnold, Michael Boxer, American Journal of Hematology ImmunodeficienciesImmunologyPharmacotherapyImmunotherapyDouble-blind Fostamatinib	2019	116
Pulmonary Hypertension in Patients Using Oral Contraceptives Robert E. Kleiger, Michael Boxer, Robert E. Ingham, CHEST Journal HypertensionContraceptionPulmonary Arterial HypertensionHormonal ContraceptiveOral Contraceptive	1976	89
Randomized phase 2 study of obinutuzumab monotherapy in symptomatic, previously untreated chronic lymphocytic leukemia John C. Byrd, Joseph M. Flynn, Thomas J. Kipps, Blood	2015	83
Anemia in Primary Hyperparathyroidism Michael Boxer Archives of Internal Medicine Bone Marrow FailureParathyroid HormoneHematologyClinical NutritionPathology	1977	83
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial Catherine M. Broome, Vickie McDonald, Yoshitaka Miyakawa, The Lancet ThrombopoiesisAutoimmune DiseaseBlood PlateletPrimary Immune ThrombocytopeniaImmunology	2023	77

Page 1